Första AP-fonden’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-95,220
Closed -$33.4M 173
2025
Q4
$33.4M Buy
95,220
+7,520
+9% +$2.54M 0.2% 89
2025
Q3
$28.3M Buy
87,700
+9,600
+12% +$2.99M 0.17% 112
2025
Q2
$30.4M Buy
78,100
+6,600
+9% +$2.65M 0.2% 94
2025
Q1
$31.1M Buy
71,500
+1,400
+2% +$562K 0.24% 78
2024
Q4
$25.9M Buy
70,100
+900
+1% +$377K 0.18% 90
2024
Q3
$36M Buy
69,200
+5,200
+8% +$2.78M 0.28% 65
2024
Q2
$34.7M Sell
64,000
-6,700
-9% -$3.54M 0.31% 57
2024
Q1
$36.7M Buy
70,700
+2,000
+3% +$995K 0.31% 59
2023
Q4
$32.4M Sell
68,700
-4,600
-6% -$2.13M 0.33% 58
2023
Q3
$31.9M Buy
73,300
+1,200
+2% +$544K 0.36% 51
2023
Q2
$32M Buy
72,100
+2,300
+3% +$1.06M 0.34% 48
2023
Q1
$32.1M Sell
69,800
-5,100
-7% -$2.43M 0.38% 52
2022
Q4
$38.4M Buy
74,900
+7,100
+10% +$3.6M 0.43% 47
2022
Q3
$30.8M Buy
67,800
+3,100
+5% +$1.48M 0.38% 56
2022
Q2
$31.2M Sell
64,700
-1,000
-2% -$495K 0.41% 50
2022
Q1
$32.3M Buy
65,700
+2,500
+4% +$1.14M 0.37% 52
2021
Q4
$29.3M Sell
63,200
-4,400
-7% -$1.85M 0.3% 67
2021
Q3
$25.2M Buy
67,600
+5,600
+9% +$2.13M 0.29% 73
2021
Q2
$23.7M Buy
62,000
+4,400
+8% +$1.68M 0.28% 71
2021
Q1
$20.7M Buy
57,600
+16,000
+38% +$5.15M 0.29% 70
2020
Q4
$13.4M Buy
41,600
+4,400
+12% +$1.35M 0.2% 110
2020
Q3
$9.99M Buy
37,200
+5,200
+16% +$1.4M 0.21% 103
2020
Q2
$8.41M Buy
32,000
+4,900
+18% +$1.31M 0.22% 109
2020
Q1
$6.15M Sell
27,100
-43,400
-62% -$11.8M 0.22% 127
2019
Q4
$21.3M Buy
70,500
+14,300
+25% +$3.94M 1.06% 27
2019
Q3
$13.5M Buy
56,200
+36,200
+181% +$9.92M 0.56% 42
2019
Q2
$5.64M Buy
+20,000
New +$5.46M 0.25% 87

Other funds holding ELV

Första AP-fonden's ELV Position: Q1 2026 in Review

Första AP-fonden sold out of Elevance Health (ELV) in Q1 2026, closing a stake of 95,220 shares — an estimated $33.4M sold.

Första AP-fonden first reported a position in ELV in Q2 2019 and held it in 27 quarters. The position peaked at $38.4M in Q4 2022. 1,466 funds tracked by Wall St. Rank hold ELV as of Q1 2026.

  • Första AP-fonden reported no remaining Elevance Health position as of Q1 2026 after selling out during the quarter.
  • Första AP-fonden sold 95,220 Elevance Health shares in Q1 2026, an estimated $33.4M.
  • Första AP-fonden first reported a position in Elevance Health in Q2 2019 and held it in 27 quarters.
  • Första AP-fonden's Elevance Health position peaked at $38.4M in Q4 2022.
  • 1,466 funds tracked by Wall St. Rank held Elevance Health as of Q1 2026.

Based on Första AP-fonden's 13F filing for Q1 2026.